Clinical trial: the effects of a fermented milk product containing <i>Bifidobacterium lactis</i> DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

Abstract

This probiotic resulted in improvements in objectively measured abdominal girth and gastrointestinal transit, as well as reduced symptomatology. These data support the concept that accelerating transit is a useful strategy for treating distension.